Offer - Urjas Oil for just ₹ 1 X
Zabesta Xlo is a commercial drug that is prescribed in the form of Tablet. Other than this, Zabesta Xlo has some other therapeutic uses, which have been discussed ahead.
The correct dosage of Zabesta Xlo depends on the patient's age, gender, and medical history. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. Refer to the dosage section for a detailed discussion.
Some other side effects of Zabesta Xlo have been listed ahead. Such side effects of Zabesta Xlo normally do not last long and go away once the treatment is completed. Please speak with your doctor if these side effects worsen or persist for a longer duration.
In addition, Zabesta Xlo's effect is Safe during pregnancy and Safe for lactating mothers. In addition, Zabesta Xlo's effects on the liver, heart and kidney are discussed below in the Zabesta Xlo related warnings section.
Zabesta Xlo can cause adverse effects in certain medical conditions. It is strongly recommended to avoid Zabesta Xlo in conditions like Diabetes, Asthma, Liver Disease. Some other conditions that can be affected by Zabesta Xlo are listed in the contraindications section below.
Drug interactions for Zabesta Xlo have been reported in the medical literature. See below for a complete list.
Along with the above-mentioned precautions, remember that taking Zabesta Xlo is considered not safe while driving, and is not addictive.
Zabesta Xlo is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Zabesta Xlo safe for pregnant women?
Pregnant women can take Zabesta Xlo without worrying about any side effects.
Is the use of Zabesta Xlo safe during breastfeeding?
Zabesta Xlo is safe for breastfeeding women.
What is the effect of Zabesta Xlo on the Kidneys?
Zabesta Xlo rarely affects the kidneys.
What is the effect of Zabesta Xlo on the Liver?
Zabesta Xlo may have mild side effects on the liver. Most people will never see any effect on the liver.
What is the effect of Zabesta Xlo on the Heart?
Side effects of Zabesta Xlo rarely affect the heart.
Zabesta Xlo should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Zabesta Xlo unless your doctor advises you to do so -
Is this Zabesta Xlo habit forming or addictive?
No, you will not get addicted to Zabesta Xlo.
Interaction between Food and Zabesta Xlo
When consumed with certain foods, Zabesta Xlo may take longer to have an effect. Contact your doctor about this.
Interaction between Alcohol and Zabesta Xlo
Taking Zabesta Xlo with alcohol can have severely harmful effects on your health.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 229
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 149
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Bisoprolol An (bisoprolol fumarate)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Bisoprolol Sandoz® (bisoprolol fumarate)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Hydrochlorothiazide
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 582-586
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 446-448